Gerald F. Cox

11.2k citations

102 papers · 6.7k indexed · 3 hit papers · h-index 42

Molecular Biology top 5%
Cardiology and Cardiovascular Medicine top 0.5%
Physiology top 1%
Epidemiology top 2%
Genetics top 2%

Co-authors: Steven E. Lipshultz Jeffrey A. Towbin Lynn A. Sleeper Steven D. Colan April M. Lowe E. John Orav Jane Messere Paul R. Lurie
Topics: Lysosomal Storage Disorders Research (42 papers)Cardiomyopathy and Myosin Studies (15 papers)Carbohydrate Chemistry and Synthesis (14 papers)
Cited by: Cardiology and Cardiovascular Medicine Physiology Clinical Biochemistry
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences The Lancet
Partner nations: United States United Kingdom France

In The Last Decade

Gerald F. Cox

100 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in Children

2006 647 citations Jeffrey A. Towbin, April M. Lowe et al. JAMA profile →
The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States

2003 542 citations Steven E. Lipshultz, Lynn A. Sleeper et al. profile →
Intracytoplasmic Sperm Injection May Increase the Risk of Imprinting Defects

2002 519 citations Gerald F. Cox, Joachim Bürger et al. The American Journal of Human Genetics profile →

Peers

Countries citing papers authored by Gerald F. Cox

Since Specialization

Citations

This map shows the geographic impact of Gerald F. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald F. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald F. Cox more than expected).

Fields of papers citing papers by Gerald F. Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald F. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald F. Cox. The network helps show where Gerald F. Cox may publish in the future.

Co-authorship network of co-authors of Gerald F. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald F. Cox. A scholar is included among the top collaborators of Gerald F. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald F. Cox. Gerald F. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inter-rater reliability of video clips to assess for obstructive sleep apnea in children 2025 ·Sleep Medicine ·Sherri L. Katz,(unknown),(unknown),(unknown),Nick Barrowman,Gerald F. Cox,(unknown),Refika Ersu	1
2	Plasma glucosylsphingosine correlations with baseline disease burden and response to eliglustat in two clinical trials of previously untreated adults with Gaucher disease type 1 2023 ·Molecular Genetics and Metabolism ·Michel Peterschmitt,Meredith C. Foster,Allena Ji,(unknown),Gerald F. Cox	4
3	Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases 2020 ·Orphanet Journal of Rare Diseases ·(unknown),Ruth Pulikottil-Jacob,(unknown),(unknown),Chad Gwaltney,(unknown),(unknown),Gerald F. Cox,Tanya Fischer,Alaa Hamed	6
4	The art and science of choosing efficacy endpoints for rare disease clinical trials 2018 ·American Journal of Medical Genetics Part A ·Gerald F. Cox	22
5	Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry 2016 ·Molecular Genetics and Metabolism ·Amal El‐Beshlawy,Anna Tylki‐Szymańska,Ashok Vellodi,Nadia Belmatoug,Gregory A. Grabowski,Edwin H. Kolodny,Julie L. Batista,Gerald F. Cox,Pramod K. Mistry	41
6	Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency 2015 ·Molecular Genetics and Metabolism ·Melissa Wasserstein,Simon Jones,Handrean Soran,George A. Díaz,Natalie Lippa,Beth L. Thurberg,Kerry Culm-Merdek,(unknown),Haig Inguilizian,Gerald F. Cox,Ana Cristina Puga	70
7	Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann–Pick disease type B (acid sphingomyelinase deficiency) 2015 ·Genetics in Medicine ·Margaret M. McGovern,Melissa Wasserstein,Brian Kirmse,W. Lane Duvall,Thomas D. Schiano,Beth L. Thurberg,Susan Richards,Gerald F. Cox	46
8	Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpoints 2015 ·Orphanet Journal of Rare Diseases ·Emil Kakkis,(unknown),Gerald F. Cox,Mark P. Hayes,Federico Goodsaid,P.K. Tandon,Pat Furlong,Susan Boynton,(unknown),(unknown),Mark Thornton	36
9	Monoallelic expression of the human FOXP2 speech gene 2014 ·Proceedings of the National Academy of Sciences ·Abidemi Adegbola,Gerald F. Cox,Elizabeth M. Bradshaw,David A. Hafler,Alexander A. Gimelbrant,Andrew Chess	30
10	Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: A comparative study from the Pediatric Cardiomyopathy Registry 2008 ·American Heart Journal ·David Connuck,Lynn A. Sleeper,Steven D. Colan,Gerald F. Cox,Jeffrey A. Towbin,April M. Lowe,James D. Wilkinson,E. John Orav,(unknown),Bonnie Anne Salbert,Steven E. Lipshultz	163
11	Abstract 2343: Outcomes in Children with Noonan Syndrome and Cardiomyopathy 2007 ·Circulation ·James D. Wilkinson,April M. Lowe,Bonnie Anne Salbert,Lynn A. Sleeper,Jeffrey A. Towbin,Steven D. Colan,Gerald F. Cox,David Connuck,(unknown),Sarah K. Clunie,Jane Messere,Steven E. Lipshultz	1
12	Encephalocraniocutaneous lipomatosis accompanied by the formation of bone cysts: Harboring clues to pathogenesis? 2007 ·American Journal of Medical Genetics Part A ·Ute Moog,Filip Roelens,Geert Mortier,(unknown),Mary Kelly,Gerald F. Cox,Caroline D. Robson,Virginia Kimonis	32
13	A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years 2006 ·Molecular Genetics and Metabolism ·(unknown),Robin Winkler Doroshow,Richard H. Hoft,(unknown),Irwin Walot,Michael J. Diament,(unknown),Kenneth R. Huff,Gerald F. Cox,Stuart J. Swiedler,Emil Kakkis	183
14	Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in Childrenbreakdown → 2006 ·JAMA ·Jeffrey A. Towbin,April M. Lowe,Steven D. Colan,Lynn A. Sleeper,E. John Orav,Sarah K. Clunie,Jane Messere,Gerald F. Cox,Paul R. Lurie,Daphne T. Hsu,Charles E. Canter,James D. Wilkinson,Steven E. Lipshultz	647
15	Retinal Function in Carriers of Bardet-Biedl Syndrome 2003 ·Archives of Ophthalmology ·Gerald F. Cox	17
16	Cardiac phenotypes in chromosome 4q− syndrome with and without a deletion of the dHAND gene 2002 ·Genetics in Medicine ·Taosheng Huang,Angela E. Lin,Gerald F. Cox,Wendy L. Golden,Gerald L. Feldman,Ute Moog,Connie Schrander‐Stumpel,Mitsuhiro Kamisago,Stefan Vermeulen	29
17	Intracytoplasmic Sperm Injection May Increase the Risk of Imprinting Defectsbreakdown → 2002 ·The American Journal of Human Genetics ·Gerald F. Cox,Joachim Bürger,Va Lip,Ulrike Mau,Karl Sperling,Bai‐Lin Wu,Bernhard Horsthemke	519
18	Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome 2002 ·Nature Genetics ·Kirk Mykytyn,Darryl Nishimura,Charles Searby,(unknown),(unknown),John S. Beck,Terry A. Braun,Luan M. Streb,Alberto S. Cornier,Gerald F. Cox,Anne B. Fulton,Rivka Carmi,Güven Lüleci,Settara C. Chandrasekharappa,Francis S. Collins,Samuel G. Jacobson,John R. Heckenlively,Richard G. Weleber,Edwin M. Stone,Val C. Sheffield	258
19	Contiguous Deletion of the X-Linked Adrenoleukodystrophy Gene (ABCD1) and DXS1357E: A Novel Neonatal Phenotype Similar to Peroxisomal Biogenesis Disorders 2002 ·The American Journal of Human Genetics ·Deyanira Corzo,William T. Gibson,(unknown),Grant A. Mitchell,(unknown),Gerald F. Cox,Robin Casey,(unknown),(unknown),Garry R. Cutting,Gerald V. Raymond,Kirby D. Smith,Paul A. Watkins,Ann B. Moser,Hugo W. Moser,Steven J. Steinberg	50
20	Etiology and family history of pediatric cardiomyopathy: the early pediatric cardiomyopathy registry (PCMR) experience 1998 ·Journal of the American College of Cardiology ·(unknown),Jeffrey A. Towbin,Michelle A. Grenier,Voula Osganian,S D Colan,Lynn A. Sleeper,Robert E. Shaddy,Gerald F. Cox,Paul R. Lurie	1

About Gerald F. Cox

Gerald F. Cox is a scholar working on Physiology, Clinical Biochemistry and Rheumatology, having authored 102 papers that have together received 6.7k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (42 papers), Cardiomyopathy and Myosin Studies (15 papers) and Carbohydrate Chemistry and Synthesis (14 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.2k citations), Physiology (2.0k citations) and Clinical Biochemistry (338 citations). Gerald F. Cox has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Steven E. Lipshultz, Jeffrey A. Towbin, Lynn A. Sleeper, Steven D. Colan, April M. Lowe, E. John Orav, Jane Messere, Paul R. Lurie, James D. Wilkinson and Louis M. Kunkel. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact